223 related articles for article (PubMed ID: 22541035)
1. [Prevention and treatment of venous thromboembolism: the place of new oral anticoagulants].
Reis A
Rev Port Cardiol; 2012 Apr; 31 Suppl 1():45-50. PubMed ID: 22541035
[TBL] [Abstract][Full Text] [Related]
2. Rivaroxaban: an oral factor Xa inhibitor.
Thomas TF; Ganetsky V; Spinler SA
Clin Ther; 2013 Jan; 35(1):4-27. PubMed ID: 23328267
[TBL] [Abstract][Full Text] [Related]
3. Management of venous thromboembolism in cancer patients and the role of the new oral anticoagulants.
Wharin C; Tagalakis V
Blood Rev; 2014 Jan; 28(1):1-8. PubMed ID: 24360911
[TBL] [Abstract][Full Text] [Related]
4. New anticoagulants in the management of venous thromboembolism in women.
Piovella F; Irina Iosub D
Thromb Res; 2015 Feb; 135 Suppl 1():S5-7. PubMed ID: 25903537
[TBL] [Abstract][Full Text] [Related]
5. Role of new anticoagulants for the prevention of venous thromboembolism after major orthopaedic surgery and in hospitalised acutely ill medical patients.
Ageno W; Spyropoulos AC; Turpie AG
Thromb Haemost; 2012 Jun; 107(6):1027-34. PubMed ID: 22437976
[TBL] [Abstract][Full Text] [Related]
6. The use of rivaroxaban for short- and long-term treatment of venous thromboembolism.
Cohen AT; Dobromirski M
Thromb Haemost; 2012 Jun; 107(6):1035-43. PubMed ID: 22371186
[TBL] [Abstract][Full Text] [Related]
7. [New oral anticoagulants for treatment of venous thromboembolism].
Espinola-Klein C; Weisser G
Dtsch Med Wochenschr; 2011 Jun; 136(22):1162-4. PubMed ID: 21611919
[TBL] [Abstract][Full Text] [Related]
8. The current landscape of treatment options for venous thromboembolism: a focus on novel oral anticoagulants.
Hull RD; Gersh MH
Curr Med Res Opin; 2015 Feb; 31(2):197-210. PubMed ID: 25299352
[TBL] [Abstract][Full Text] [Related]
9. Profile of betrixaban and its potential in the prevention and treatment of venous thromboembolism.
Chan NC; Bhagirath V; Eikelboom JW
Vasc Health Risk Manag; 2015; 11():343-51. PubMed ID: 26170684
[TBL] [Abstract][Full Text] [Related]
10. Use of emerging oral anticoagulants in clinical practice: translating results from clinical trials to orthopedic and general surgical patient populations.
Merli G; Spyropoulos AC; Caprini JA
Ann Surg; 2009 Aug; 250(2):219-28. PubMed ID: 19638915
[TBL] [Abstract][Full Text] [Related]
11. Old and new oral anticoagulants for venous thromboembolism and atrial fibrillation: a review of the literature.
Becattini C; Vedovati MC; Agnelli G
Thromb Res; 2012 Mar; 129(3):392-400. PubMed ID: 22264937
[TBL] [Abstract][Full Text] [Related]
12. Novel oral anticoagulants for prophylaxis and treatment of venous thromboembolism: part I (Factor Xa inhibitors).
Mehta RS
Expert Rev Hematol; 2010 Apr; 3(2):227-41. PubMed ID: 21083465
[TBL] [Abstract][Full Text] [Related]
13. New anticoagulants for treatment of venous thromboembolism.
Franchini M; Mannucci PM
Eur J Intern Med; 2012 Dec; 23(8):692-5. PubMed ID: 23095463
[TBL] [Abstract][Full Text] [Related]
14. Implications of new anticoagulants in primary practice.
Perez A; Eraso LH; Merli GJ
Int J Clin Pract; 2013 Feb; 67(2):139-56. PubMed ID: 23305476
[TBL] [Abstract][Full Text] [Related]
15. Direct oral anticoagulants and venous thromboembolism.
Franchini M; Mannucci PM
Eur Respir Rev; 2016 Sep; 25(141):295-302. PubMed ID: 27581829
[TBL] [Abstract][Full Text] [Related]
16. Factor Xa inhibitors--new anticoagulants for secondary haemostasis.
Perzborn E
Hamostaseologie; 2009 Aug; 29(3):260-7. PubMed ID: 19644596
[TBL] [Abstract][Full Text] [Related]
17. Use of New Oral Anticoagulants in the Treatment of Venous Thromboembolism and Thrombotic Prophylaxis.
Akin M; Schäfer A; Akin I; Widder J; Brehm M
Cardiovasc Hematol Disord Drug Targets; 2015; 15(2):92-6. PubMed ID: 26666324
[TBL] [Abstract][Full Text] [Related]
18. Development and clinical applications of novel oral anticoagulants. Part I. Clinically approved drugs.
Ahrens I; Peter K; Lip GY; Bode C
Discov Med; 2012 Jun; 13(73):433-43. PubMed ID: 22742649
[TBL] [Abstract][Full Text] [Related]
19. Treatment and secondary prevention of venous thromboembolism in cancer patients. Current strategies and new therapeutic options.
Ay C; Pabinger I
Hamostaseologie; 2012; 32(2):139-44. PubMed ID: 21822525
[TBL] [Abstract][Full Text] [Related]
20. Rivaroxaban and dabigatran etexilate: two new oral anticoagulants for extended postoperative prevention of venous thromboembolism after elective total hip arthroplasty.
Borris LC
Arch Orthop Trauma Surg; 2010 May; 130(5):583-9. PubMed ID: 19565250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
